Is UPHL or BTTX more profitable?

Company Net Margins Return on Equity Return on Assets UpHealth N/A N/A N/A Better Therapeutics N/A N/A N/A

Do analysts prefer ADTX or UPHL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aditxt 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 UpHealth 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, ADTX or UPHL?

Aditxt has higher earnings, but lower revenue than UpHealth. Aditxt is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aditxt $14.34K 0.45 -$41.71M -$100.79 thousand N/A UpHealth $130M 0.00 -$56.42M $1.98 0.00

Is ADTX or UPHL more profitable?

UpHealth has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. UpHealth's return on equity of 0.00% beat Aditxt's return on equity. Company Net Margins Return on Equity Return on Assets Aditxt -360,152.50% -374.60% -105.93% UpHealth N/A N/A N/A

Is UPHL or GNCA more profitable?

UpHealth's return on equity of 0.00% beat Genocea Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets UpHealth N/A N/A N/A Genocea Biosciences N/A -182.88% -62.76%

Is PXMD or UPHL more profitable?

UpHealth's return on equity of 0.00% beat PaxMedica's return on equity. Company Net Margins Return on Equity Return on Assets PaxMedica N/A -3,167.89% -560.35% UpHealth N/A N/A N/A

Is UPHL or ARDS more profitable?

Company Net Margins Return on Equity Return on Assets UpHealth N/A N/A N/A Aridis Pharmaceuticals N/A N/A N/A

UpHealth (UPHL) Competitors

$0.0001 0.00 (0.00%)

As of 09/8/2026 12:10 PM Eastern

Compare

UPHL vs. BTTX, ADTX, GNCA, PXMD, and ARDS

Should you buy UpHealth stock or one of its competitors? UpHealth's main competitors and comparable companies include Better Therapeutics (BTTX), Aditxt (ADTX), Genocea Biosciences (GNCA), PaxMedica (PXMD), and Aridis Pharmaceuticals (ARDS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does UpHealth compare to Better Therapeutics?

UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

UpHealth has a beta of 0.33, suggesting that its share price is 67% less volatile than the broader market. Comparatively, Better Therapeutics has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company	Overall Sentiment
UpHealth	Neutral
Better Therapeutics	Neutral

Company	Net Margins	Return on Equity	Return on Assets
UpHealth	N/A	N/A	N/A
Better Therapeutics	N/A	N/A	N/A

56.1% of UpHealth shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Better Therapeutics has lower revenue, but higher earnings than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00
Better Therapeutics	N/A	N/A	-$39.76M	-$0.39	N/A

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aditxt?

Aditxt (NASDAQ:ADTX) and UpHealth (NYSE:UPHL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability.

Aditxt has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market. Comparatively, UpHealth has a beta of 0.33, indicating that its share price is 67% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aditxt	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
UpHealth	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

UpHealth has a net margin of 0.00% compared to Aditxt's net margin of -360,152.50%. UpHealth's return on equity of 0.00% beat Aditxt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aditxt	-360,152.50%	-374.60%	-105.93%
UpHealth	N/A	N/A	N/A

15.5% of Aditxt shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 0.0% of Aditxt shares are held by company insiders. Comparatively, 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Aditxt has higher earnings, but lower revenue than UpHealth. Aditxt is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aditxt	$14.34K	0.45	-$41.71M	-$100.79 thousand	N/A
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00

In the previous week, Aditxt's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company	Overall Sentiment
Aditxt	Neutral
UpHealth	Neutral

Summary

UpHealth beats Aditxt on 7 of the 12 factors compared between the two stocks.

How does UpHealth compare to Genocea Biosciences?

UpHealth (NYSE:UPHL) and Genocea Biosciences (NASDAQ:GNCA) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

UpHealth has a beta of 0.33, suggesting that its share price is 67% less volatile than the broader market. Comparatively, Genocea Biosciences has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.

Company	Overall Sentiment
UpHealth	Neutral
Genocea Biosciences	Neutral

56.1% of UpHealth shares are held by institutional investors. Comparatively, 0.6% of Genocea Biosciences shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 1.6% of Genocea Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

UpHealth's return on equity of 0.00% beat Genocea Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
UpHealth	N/A	N/A	N/A
Genocea Biosciences	N/A	-182.88%	-62.76%

Genocea Biosciences has lower revenue, but higher earnings than UpHealth. Genocea Biosciences is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00
Genocea Biosciences	$1.91M	0.00	-$33.20M	-$0.61	N/A

Summary

UpHealth beats Genocea Biosciences on 7 of the 9 factors compared between the two stocks.

How does UpHealth compare to PaxMedica?

PaxMedica (NASDAQ:PXMD) and UpHealth (NYSE:UPHL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

4.9% of PaxMedica shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 1.0% of PaxMedica shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

UpHealth's return on equity of 0.00% beat PaxMedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PaxMedica	N/A	-3,167.89%	-560.35%
UpHealth	N/A	N/A	N/A

PaxMedica has a beta of -0.99, indicating that its stock price is 199% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.33, indicating that its stock price is 67% less volatile than the broader market.

In the previous week, PaxMedica's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company	Overall Sentiment
PaxMedica	Neutral
UpHealth	Neutral

PaxMedica has higher earnings, but lower revenue than UpHealth. PaxMedica is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PaxMedica	N/A	N/A	-$18.29M	-$6.09	N/A
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00

Summary

UpHealth beats PaxMedica on 8 of the 9 factors compared between the two stocks.

How does UpHealth compare to Aridis Pharmaceuticals?

UpHealth (NYSE:UPHL) and Aridis Pharmaceuticals (NASDAQ:ARDS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

Aridis Pharmaceuticals has lower revenue, but higher earnings than UpHealth. UpHealth is trading at a lower price-to-earnings ratio than Aridis Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UpHealth	$130M	0.00	-$56.42M	$1.98	0.00
Aridis Pharmaceuticals	N/A	N/A	-$30.37M	$0.31	0.00

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Aridis Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
UpHealth	Neutral
Aridis Pharmaceuticals	Neutral

56.1% of UpHealth shares are held by institutional investors. Comparatively, 9.6% of Aridis Pharmaceuticals shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 5.5% of Aridis Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

UpHealth has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market. Comparatively, Aridis Pharmaceuticals has a beta of 49.95, suggesting that its stock price is 4,895% more volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
UpHealth	N/A	N/A	N/A
Aridis Pharmaceuticals	N/A	N/A	N/A

Summary

UpHealth beats Aridis Pharmaceuticals on 4 of the 7 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UPHL vs. The Competition

Export

Metric	UpHealth	Health services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$2K	$923.67K	$7.22B	$23.49B
Dividend Yield	N/A	N/A	2.55%	3.76%
P/E Ratio	0.00	N/A	271.78	28.73
Price / Sales	0.00	0.00	709.75	20.66
Price / Cash	N/A	N/A	77.55	34.36
Price / Book	0.00	0.00	10.63	4.74
Net Income	-$56.42M	-$48.09M	$3.48B	$1.07B
7 Day Performance	N/A	N/A	-1.19%	-1.44%
1 Month Performance	N/A	N/A	1.99%	-1.99%
1 Year Performance	N/A	N/A	21.91%	11.68%

UpHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UPHL UpHealth	N/A	$0.00 flat	N/A	-50.0%	$2K	$130M	N/A	1,750	Gap Down High Trading Volume
BTTX Better Therapeutics	N/A	N/A	N/A	N/A	$4K	N/A	N/A	40
ADTX Aditxt	0.112 of 5 stars	$0.01 flat	N/A	-100.0%	$6K	$14.34K	N/A	60	Gap Down
GNCA Genocea Biosciences	N/A	N/A	N/A	N/A	$6K	$1.91M	N/A	70
PXMD PaxMedica	N/A	$0.00 flat	N/A	N/A	$6K	N/A	N/A	2

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 9/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UpHealth (UPHL) Competitors

UPHL vs. BTTX, ADTX, GNCA, PXMD, and ARDS

How does UpHealth compare to Better Therapeutics?

Summary

How does UpHealth compare to Aditxt?

Summary

How does UpHealth compare to Genocea Biosciences?

Summary

How does UpHealth compare to PaxMedica?

Summary

How does UpHealth compare to Aridis Pharmaceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPHL vs. The Competition

UpHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

UpHealth (UPHL) Competitors

UPHL vs. BTTX, ADTX, GNCA, PXMD, and ARDS

How does UpHealth compare to Better Therapeutics?

Which has more volatility and risk, UPHL or BTTX?

Does the media prefer UPHL or BTTX?

Is UPHL or BTTX more profitable?

Do institutionals and insiders hold more shares of UPHL or BTTX?

Which has stronger earnings & valuation, UPHL or BTTX?

Summary

How does UpHealth compare to Aditxt?

Which has more volatility and risk, ADTX or UPHL?

Do analysts prefer ADTX or UPHL?

Is ADTX or UPHL more profitable?

Do insiders & institutionals hold more shares of ADTX or UPHL?

Which has preferable valuation and earnings, ADTX or UPHL?

Does the media prefer ADTX or UPHL?

Summary

How does UpHealth compare to Genocea Biosciences?

Which has more volatility & risk, UPHL or GNCA?

Does the media refer more to UPHL or GNCA?

Do insiders & institutionals have more ownership in UPHL or GNCA?

Is UPHL or GNCA more profitable?

Which has higher earnings and valuation, UPHL or GNCA?

Summary

How does UpHealth compare to PaxMedica?

Do institutionals & insiders believe in PXMD or UPHL?

Is PXMD or UPHL more profitable?

Which has more volatility and risk, PXMD or UPHL?

Does the media prefer PXMD or UPHL?

Which has better earnings and valuation, PXMD or UPHL?

Summary

How does UpHealth compare to Aridis Pharmaceuticals?

Which has higher earnings & valuation, UPHL or ARDS?

Does the media refer more to UPHL or ARDS?

Do insiders & institutionals hold more shares of UPHL or ARDS?

Which has more risk & volatility, UPHL or ARDS?

Is UPHL or ARDS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPHL vs. The Competition

UpHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools